Clinical Cancer Research Publishes Study Demonstrating Clinically Meaningful and Statistically Significant Prognostic Improvement by the Breast Cancer Index(SM) Over Oncotype DX® in Early-Stage, Estrogen Receptor-Positive, Lymph Node-Negative Breast…

… , estrogen receptor-positive (ER+), lymph node-negative breast cancer patients, BCI out-performed Oncotype DX … the validated commercially-available assays.  
"Breast Cancer Index, a second generation tool … with lymph node-negative, hormone receptor-positive breast cancer treated with either tamoxifen or …